Story of Influenza Antivirals: Part 38

Transparency

You may recall that we summed up the antiviral story in August 2023 in the 36th post of the series. In the 37th post, we provided a series of references to the story up to 2014. They included information on where to find the clinical study reports (CSRs) of the 107 studies (mainly trials) carried out on oseltamivir (Tamiflu) and zanamivir (Relenza), which took us 4 years to obtain from their respective manufacturers.